CCM/Market Reports-/The Paracetamol Industry in China

¡¡

(home)
CCM
consultancy
Market reports
Trade Analysis
newsletters & Information
conferences & events
coming report
ValoTracer
about us
careers 
contact
Always Primary Findings
Online Payment
samples
 

click here for sample pages

 

CCM>Market Reports>

 

No. 0005P004 The Paracetamol Industry in China  - Edition(5)

 

 

About This Report:

 

Report edition:  2008 edition(5)
Language version: English
Document type: PDF File,(*.pdf)
For ready report --    
  Finished in: Dec 2008 ,edition(5)
  Total pages: 141
  Delivery: Delivery within 1-1 work days by email
  Price/copy: - USD8000.00 for single user
    -USD17600.00 for corporate license/site license
For update report --  
  Delivery time: Delivery within 20-40 work days upon confirmation
  Price/copy: - USD10000.00 for single user PDF
    - USD25000.00 for corporate license/site license

 

* The corporate license/site license is only for the sole and confidential use within the subscriber company and its affiliates in which the subscriber company owns, directly or indirectly, a fifty percent or greater, financial interest.

 

Report Edition List:

 

Version Finished in Availability Language   Pages   Delivery Price/Copy (For single user)
update report - update on request English - within 20-40 work days upon confirmation USD10000.00
2008,edition(5) Dec,2008 available English 141 within 1-1 work days by email USD8000.00
2006,edition(4) Mar,2006 available English 174 within 1-1 work days by email USD8000.00

 

 

Description:

 

Paracetamol, which takes the most important position among NSAIDs, has kept growing worldwide in recent years. China, the export-oriented paracetamol producer, has witnessed fast expanding capacity and output from 1998 to 2007.

China's fast capacity and output is largely attributed to its export, which consitutes more than 60% of China's total output. As one of main paracetamol manufacturers in the world, China's paracetamol export has constituted 30%-40% of the world total consumption. China's export volume has maintained fast growth in recent years.

However, with Chinese goverment's lowering the export tax rebate of paracetamol in 2007, China's paracetamol exported has been affected, with little growth of the export volume in 2008 than that in 2006. With the fluctuating crude oil prices and the global financial crisis, what has happened and will happen to China's paracetamol export in 2008?

To further penetrate into the industry, especially the future situation, CCM has produced a report of The Paracetamol Industry in China, which will provide you with the answers to the following questions:

What is the situation of NSAIDs and the position of paracetamol in NSAIDs now in China?
What is the current situation and trends of paracetamol production in China?
How has China's paracetamol import and export changed in the past years, especially in 2007 and Jan-Aug 2008?

Is the consumption of paracetamol growing in China?
What is the future of paracetamol industry in China till 2015?

 

Main Content:

 

No. Content
Page
Executive Summary
5
Methodology
8
I Production & market information
9
I-1 General situation of NSAIDs in China
9
I-2 Introduction of main NSAIDs
10
I-2.1 Paracetamol
10
I-2.1.1 Property of paracetamol
10
I-2.1.2 Position of paracetamol among the NSAID drug
12
I-2.2 Aspirin
12
I-2.3 Analgin
13
I-2.4 Ibuprofen
14
I-2.5 Naproxen and dichlofenac
15
I-3 Brief review of paracetamol industry in China
18
I-4 Competition from other countries
23
I-5 Production situation of paracetamol in 2008
27
I-5.1 Summary of Chinese manufacturers
27
I-5.2 Supply situation of raw materials
34
I-6 Pricing of paracetamol
35
I-6.1 Pricing in the past
35
I-6.2 Pricing in 2008
37
I-7 Import and export of paracetamol in China
39
I-7.1 Export analysis of paracetamol in the past
39
I-7.1.1 Export analysis: situation of price, volume and export value
40
I-7.1.2 Export analysis: situation of destination
41
I-7.1.3 Export analysis: situation of exporter
42
I-7.1.4 Export analysis: situation of manufacturers
43
I-7.2 Import analysis of paracetamol in the past
46
I-7.3 Export analysis of paracetamol in 2007, Jan-Aug 2008
48
I-7.4 Import analysis of paracetamol in 2007, Jan-Aug 2008
53
I-8 Brief introduction to consumption of paracetamol in China
54
I-8.1 Apparent consumption of paracetamol in China
54
I-8.2 Brief introduction the application of paracetamol
56
I-8.3 Brief introduction to paracetamol preparations in China
56
I-8.4 The usages of paracetamol preparations in Chinese hospitals
57
I-8.5 Side effects of paracetamol
58
I-8.6 Brief introduction of the drugs for cold in China in 2007
58
I-9 Government management on paracetamol industry in China
62
I-10 Dumping issue of Chinese paracetamol
65
I-11 Mass balance between p-nitrochlorbenzene, p-nitrophenol, PAP and paracetamol in 2007
68
I-12 Forecast on paracetamol industry in next 5-10 years
69
I-12.1 Key factors and driven forces for development of paracetamol in China
69
I-12.1.1 Drivers
69
I-12.1.2 Restraints
69
I-12.2 Forecast on paracetamol industry in next 5-10 years
70
I-12.2.1 Introduction to forecast
70
I-12.2.2 Forecast on paracetamol: output, export and domestic consumption to 2015
71
II Profile of Chinese manufacturers
74
II-1 Active manufacturers of paracetamol
74
II-1-01 Shandong Anqiu Lu'an Pharmaceutical Co., Ltd.
74
II-1-13 Jiangsu World Kindly pharmaceutical Co., Ltd.
130
II-2 Idled manufacturers of paracetamol
131
II-2-01 Guangdong Jinshi General Pharmaceutical Factory
131
II-2-02 Shaanxi Nuoke Pharmaceutical Co., Ltd
133
II-3 Stopped manufacturers of paracetamol
137
II-3-01 Henan Jiaozuo Xin'an Pharmaceutical Co., Ltd.
137

LIST OF TABLES
Table 1 RMB/USD exchange rate, 1994-2008
Table I-2.3-1 Situation of analgin in China, 1990-2007
Table I-2.5-1 Output of major NSAID bulk pharmaceuticals in China, 2000-2007
Table I-3.1 Overview of paracetamol industry development in China
Table I-3-2 Paracetamol summary in the past decades
Table I-4-1 Annual capacity of major paracetamol producers in the US and Europe in 2003
Table I-4-2 Import volume &value of paracetamol in India from China, 2002- Jan-Aug, 2008
Table I-5.1-1 Production summary of paracetamol in the past years
Table I-5.1-2 SWOT analysis of China’s top five paracetamol manufacturers
Table I-6.1-1 Price of bulk paracetamol in China in the past years
Table I-7.1-1 Main items of export data from China Customs
Table I-7.1.1-1 Export volume, average export price and value of paracetamol in the past years
Table I-7.1.2-1 Export destination of Chinese paracetamol 2001-2008
Table I-7.1.4-1 Export situation of paracetamol manufacturers 2004-2005
Table I-7.1.4-2 Export situation of paracetamol manufacturers 2007, Jan-Aug 2008
Table I-7.2-1 Import of paracetamol in China in the past years
Table I-7.2-2 Import situation of paracetamol in China in 2004
Table I-7.2-3 Import situation of paracetamol in China in 2005
Table I-7.3-1 Export price of paracetamol in 2007
Table I-7.3-2 Export price of paracetamol in Jan-Aug 2008
Table I-7.3-3 Export destination of paracetamol in 2007 (breakdown by country)
Table I-7.3-4 Exporters of paracetamol in 2007
Table I-7.3-5 Export of paracetamol manufacturers in 2007
Table I-8.1-1 Production and consumption situation of paracetamol in China, 1993-2007, tonne
Table I-8.3-1 List of some major paracetamol-containing preparations in China in 2008
Table I-8.4-1 Output of paracetamol-containing preparations in China, 2002-2007
Table I-8.6-1 Major end users of bulk or DC grade paracetamol in China in 2008
Table I-9-1 Pharmaceutical manufacturers requested to make rectification by State Food and Drug Administration（SFDA）in China
Table I-9-2 New or updated laws and regulations related to pharmaceutical production in China, 2007-2008
Table I-10-1 Final judgment on the paracetamol produced in China, March 1st, 2005
Table I-12.2.1-1 Assumptions of the future GDP growth in China
Table I-12.2.2-1 Trends influencing paracetamol development
Table I-12.2.2-2 Historical growth rate of paracetamol output in China, 2004-2007
Table II-1.01-1 Economic data of Lu’an Pharm 2006-2007
Table II-1.01-2 Production of paracetamol in Lu’an Pharm in the past few years
Table II-1.01-3 Major destinations for the export of paracetamol from Lu’an Pharm in 2002-2007
Table II-1.01-4 Quoted prices of Lu’an Pharm’s paracetamol in past years
Table II-1.02-1 Production of paracetamol in Zhejiang Conler in the past few years
Table II-1.02-2 Major destinations for the export of paracetamol from Zhejiang Conler in 2002-2007
Table II-1.03-1 Production of paracetamol in Hebei Jiheng in the past few years
Table II-1.03-2 Major destinations for the export of paracetamol from Hebei Jiheng in 2002-2007
Table II-1.04-1 Production of paracetamol in Wuxi Shanhe (Wuxi Rhodia) in the past few years
Table II-1.04-2 Major destinations for the export of paracetamol from Rhodia Wuxi in 2002-2007
Table II-1.05-1 Major destinations for the export of paracetamol from Bengbu Bayi in 2002-2007
Table II-1.06-1 Production of paracetamol in Zhejiang Konch in the past few years
Table II-1.06-2 Major destinations for the export of paracetamol from Zhejiang Konch in 2002-2005
Table II-1.07-1 Production of paracetamol in Jilin Baikang in the past few years
Table II-1.07-2 Major destinations for the export of paracetamol from Jilin Baikang in 2003-2005
Table II-1.08-1 Production of paracetamol in Jiangsu Huagang in the past few years
Table II-1.08-2 Major destinations for the export of paracetamol from Jiangsu Huagang in 2003-2007
Table II-1.10-1 Production of paracetamol in Anhui Jiameng in the past few years
Table II-1.10-2 Major destinations for the export of paracetamol from Anhui Jiameng in 2002-2005
Table II-1.11-1 Major destinations for the export of paracetamol from Liaoning Tiancheng in 2003-2005
Table II-1.12-1 Production of paracetamol in Anhui Yong’an in the past few years
Table II-1.12-2  Major destinations for the export of paracetamol from Anhui Yong’an in 2003-2005
Table II-2.01-1 Production of paracetamol in Guangdong Jinshi in the past few years
Table II-2.01-2 Major destinations for the export of paracetamol from Guangdong Jinshi in 2003-2005
Table II-2.02-1 Production of paracetamol in Shaanxi Nuoke in the past few years
Table II-2.02-2 Major destinations for the export of paracetamol from Shaanxi Nuoke in 2003-2005
Table II-3.01-1 Production of paracetamol in Henan Xin’an in the past few years
Table II-3.01-2 Majorestinations for the export of paracetamol from Henan Xin’an in 2003-2005

LIST OF FIGURES
Figure 1 Forecast on paracetamol production from 2009-2015
Figure I-1-1 Output share of main species of NSAID medicine in China, 2007
Figure I-2.4-1 Export situation of ibuprofen in China, 2002-2007
Figure I-2.5-1 Output of Chinese naproxen, 2000-2007
Figure I-5-1 Capacity and output of Chinese paracetamol, 2003-2007
Figure I-5.1-1 Geographical distribution of active paracetamol producers in China in 2008
Figure I-6.2-1 Price of paracetamol, PAP and benzene in China, 1998-2007
Figure I-7.1.2-1 Share changes in top 6 export destinations of Chinese paracetamol, 2005, 2007 and Jan-Aug 2008, by export volume
Figure I-7.1.3-1 Share changes of manufacturers and exporters in exporting paracetamol, 2004, 2005, 2007, Jan-Aug 2008, by export volume
Figure I-7.1.4-1 China’s export volume of DC and bulk paracetamol 2004-2005, 2007, Jan-Aug 2008
Figure I-7.3-1 Export destination structure of Chinese paracetamol in 2007, by continent
Figure I-8.1-1 Consumption of paracetamol in China, 2000-2007
Figure I-12.2.1-1 China’s GDP growth, 2003-2007
Figure I-12.2.2-1 Forecast on output of paracetamol in China, 2008-2015
Figure I-12.2.2-2 Forecast on China’s export of paracetamol, 2008-2015
Figure I-12.2.2-3 Forecast on domestic consumption of paracetamol, 2008-2015

Part of Report: click here for sample pages

Executive Summary

(Note: The following summary is based on the situation in 2008 and maybe different to what it is nowadays. Please be noted.)

- NSAIDs

There are dozens of NSAIDs in Chinese market, among which paracetamol takes the most important position, accounting for around *% of total NSAID output and others with large output include aspirin, analgin, ibuprofen. NSAID produced in China is mainly for export with the export volume constituting over *% of total output every year.

- Capacity and output
China’s capacity of paracetamol has been increasing all the time, reaching *t/a in 2008, while in 2003, it was *t/a. China’s paracetamol is in oversupply nowadays.

- Manufacturer
By October 2008, there are * paracetamol manufacturers in China, * of them claim to have the capacity of more than *t/a each.

In 2008, among all the active paracetamol manufacturers in China, Lu’an Pharm is NO.* manufacturer of paracetamol with the capacity of *t/a, which is the major paracetamol exporter and supplier for domestic market.

All of the domestic manufacturers use acetylation of glacial acetic acid to produce paracetamol.

- Export
The majority of the paracetamol produced in China, about *, is exported. The price of the paracetamol in China is very low because of its low cost. In 2005, the paracetamol producers encountered the antidumping cases filed by the countries in Asia, such as India and Indonesia. Six of the producers have won the case in Indonesia, but the antidumping tax charged on the paracetamol from Lu’an, the largest exporter to Indonesia in China is *%.

From 1998-2007 the export of Chinese paracetamol increased with a CAGR of *%. In 2005, 2006 and 2007, the total export volume of paracetamol is * tonnes, * tonnes and * tonnes.

- Consumption
The domestic consumption of paracetamol has been increased from about * tonnes in 1993 to * tonnes in 2005, * tonnes in 2006 and * tonnes in 2007, respectively.

- Future
As to the future situation of paracetamol industry in China, the CAGR of domestic consumption and export volume of paracetamol will be *%, *%, respectively, from 2009 to 2015. The import volume will remain very small. The future capacity and output of paracetamol can meet the increment of domestic consumption and export. The figure below shows the future output of paracetamol in China.

......

(The rest content of this report is omitted.)

Character of CCM' Report:

This multi-client report provides a comprehensive study on the researched subject in China, from aspects of production, technology, import & export, consumption & end uses, etc.

>>
 All the producers in China, either active or idled or potential, have been sourced and contacted. Their situation has been verified and compiled as in the appendix.
>>
 The competitiveness of Chinese production has been discussed in order to uncover the mystery of ever-increasing capability of Chinese manufacturing.
>>
 The import & export analysis for the situation in the recent three years has been conducted.
>>
 The consumption pattern of the researched subject has been carried out in order to breakdown the end uses into different segments. The major end users under each major end use segments have been identified.
>>
 The scientific methodology has been employed to conduct the quantitative forecast on this subject in the future 5-10 years.

The aim of this report is to provide powerful assistance to the strategy group and the management team in making correct decision as how to penetrate the ever-increasing China market and how to catch the maximum commercial opportunities. The report is formulated independently by CCM’s professional market researchers, based on the first-hand and primary data which are analyzed by scientific methodology, confirmed with both manufacturers/end users/traders and legal authorities, and presented in a logic way.

Remark:

If you are not satisfied with the above main content, or if you would like to add additional requirements to the mentioned subject, or if you could not find your interested item(s) via the search engine, you are advised to go to Single-Client Services and Advisor, or Contact Us.